Pharma & Biotech

BioNxt Solutions has unveiled a strategic pivot designed to position the company at the forefront of one of the pharmaceutical...

Roche has secured significant regulatory approvals across two major markets, delivering a strategic boost to its high-margin diagnostics business. The...

For investors in Telix Pharmaceuticals, 2026 is shaping up to be a defining period. The company’s commercial prospects hinge on...

BioNTech's stock has faced significant headwinds from founder transitions and subdued financial forecasts. However, developments within its research pipeline offer...

Investors in biotechnology firm ImmunityBio are navigating a landscape of stark contrasts. The company's commercial prospects appear increasingly bright, driven...

Eli Lilly and Company is approaching a pivotal period marked by two significant catalysts. While the pharmaceutical giant's stock has...

Danish pharmaceutical giant Novo Nordisk has achieved a landmark regulatory victory with the U.S. Food and Drug Administration (FDA) granting...

The Swiss hearing solutions group Sonova is taking decisive action to refine its business focus. By announcing the sale of...

Tempus AI Inc. finds its equity trading at a critical juncture. The stock reached a new annual low of €36.80...

Bayer's ongoing corporate restructuring is encountering turbulence from two significant external forces. As geopolitical tensions flare and energy costs climb,...